🇺🇸 FDA
Patent

US 12187804

Multivalent and multispecific 41BB-binding proteins

granted A61PA61P29/00A61P35/00

Quick answer

US patent 12187804 (Multivalent and multispecific 41BB-binding proteins) held by Inhibrx Biosciences, Inc. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx Biosciences, Inc.
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P29/00, A61P35/00, A61P37/04, A61P43/00